Celanese Corp (CE) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$2.22	$2.45	+10.4%	—	$2.8B	—
Q1 26	$0.9	$0.85	-5.6%	—	$2.3B	—
Q4 25	$0.91	$0.67	-26.4%	—	$2.2B	—
Q3 25	$1.22	$1.34	+9.8%	—	$2.4B	—
Q2 25	$1.4	$1.44	+2.9%	—	$2.5B	—
Q1 25	$0.39	$0.57	+46.2%	—	$2.4B	—
Q4 24	$1.2	$1.45	+20.8%	—	$2.4B	—
Q3 24	$2.84	$2.44	-14.1%	—	$2.6B	—
Q2 24	$2.74	$2.38	-13.1%	—	$2.7B	—
Q1 24	$1.91	$2.08	+8.9%	—	$2.6B	—
Q4 23	$2.31	$2.24	-3.0%	—	$2.6B	—
Q3 23	$2.23	$2.5	+12.1%	—	$2.7B	—
Q2 23	$2.48	$2.17	-12.5%	—	$2.8B	—
Q1 23	$1.64	$2.01	+22.6%	—	$2.9B	—
Q4 22	$1.66	$1.44	-13.3%	—	$2.3B	—
Q3 22	$3.98	$3.94	-1.0%	—	$2.3B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	-$10.6	—	—	$9.5B	—
FY24	—	-$13.9	—	—	$10.3B	—
FY23	—	$18	—	—	$10.9B	—
FY22	—	$17.5	—	—	$9.7B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$5.4B	$6.1B	$7.2B	$6.3B	$5.7B	$8.5B	$9.7B	$10.9B	$10.3B	$9.5B
YoY change	-5.02%	+13.9%	+16.5%	-12%	-10.2%	+51%	+13.3%	+13.1%	-6.03%	-7.16%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	5.4B	6.1B	7.2B	6.3B	5.7B	8.5B	9.7B	10.9B	10.3B	9.5B
Cost of revenue	4B	4.6B	5.2B	4.7B	4.4B	5.9B	7.3B	8.3B	7.9B	7.6B
Gross profit	1.4B	1.5B	2B	1.6B	1.3B	2.7B	2.4B	2.6B	2.4B	2B
Gross margin	26.1%	24.6%	27.6%	25.5%	22.9%	31.4%	24.6%	23.8%	22.9%	20.5%
Research & development	78M	73M	72M	67M	74M	86M	112M	146M	130M	125M
Selling, general & administrative	378M	496M	546M	483M	482M	633M	824M	1.1B	1B	899M
Operating expenses	456M	569M	618M	550M	556M	719M	936M	1.2B	1.2B	1B
Operating income	940M	922M	1.3B	1B	715M	1.9B	1.4B	1.2B	1B	764M
Operating margin	17.4%	15%	18.6%	16.4%	12.6%	22.7%	14.3%	11.1%	10.1%	8.01%
Non-operating income, net	214M	273M	300M	69M	1.6B	402M	375M	653M	-1.4B	-1.2B
Pretax income	1B	1.1B	1.5B	988M	2.3B	2.2B	1.4B	1.2B	-996M	-1.2B
Income tax	122M	213M	292M	124M	247M	330M	-489M	-790M	510M	-90M
Net income	906M	849M	1.2B	858M	2B	1.9B	1.9B	2B	-1.5B	-1.2B
Net margin	16.8%	13.8%	17%	13.6%	35.2%	22.2%	19.7%	18%	-14.7%	-12.1%
EBITDA	1.3B	1.5B	1.9B	1.5B	1.2B	2.6B	2.2B	2B	2.1B	1.7B
EPS	6.21	6.11	8.99	6.88	16.9	17	17.5	18	-13.9	-10.6
Diluted EPS	6.18	6.09	8.91	6.84	16.8	16.9	17.3	17.9	-13.9	-10.6

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	2.7B	2.6B	2.6B	2.7B	2.6B	2.4B	2.4B	2.5B	2.4B	2.2B	2.3B	2.8B
Cost of revenue	2B	2B	2.1B	2B	2B	1.8B	1.9B	2B	1.9B	1.8B	1.9B	2.1B
Gross profit	673M	613M	554M	641M	622M	539M	476M	535M	521M	423M	468M	618M
Gross margin	24.7%	23.9%	21.2%	24.2%	23.5%	22.7%	19.9%	21.1%	21.5%	19.2%	20%	22.5%
Research & development	32M	32M	34M	33M	32M	31M	31M	31M	31M	32M	28M	29M
Selling, general & administrative	244M	270M	265M	253M	248M	262M	230M	213M	231M	223M	226M	251M
Operating expenses	276M	302M	299M	286M	280M	293M	261M	244M	262M	255M	254M	280M
Operating income	356M	271M	214M	317M	302M	206M	175M	249M	217M	128M	174M	299M
Operating margin	13.1%	10.5%	8.2%	12%	11.4%	8.69%	7.33%	9.83%	8.97%	5.81%	7.45%	10.9%
Non-operating income, net	531M	27M	99M	30M	45M	-1.6B	20M	56M	-1.4B	92M	82M	19M
Pretax income	714M	132M	157M	183M	183M	-1.5B	-3M	135M	-1.4B	13M	82M	142M
Income tax	-236M	-575M	33M	29M	61M	387M	9M	-77M	-7M	-15M	33M	11M
Net income	949M	701M	124M	153M	120M	-1.9B	-17M	202M	-1.4B	22M	48M	129M
Net margin	34.9%	27.3%	4.75%	5.77%	4.53%	-80.6%	-0.71%	7.98%	-55.9%	1%	2.05%	4.69%
EBITDA	561M	484M	523M	589M	585M	412M	364M	480M	470M	386M	432M	557M
EPS	8.73	6.41	1.11	1.42	1.06	-17.5	-0.19	1.82	-12.4	0.17	0.4	1.14
Diluted EPS	8.69	6.37	1.1	1.41	1.06	-17.5	-0.19	1.81	-12.4	0.17	0.4	1.13

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	11.4B	14.8B	12.1B	15.3B	15.3B	18.7B	11.1B	16.9B	7.6B	4.6B	5B
Enterprise value	13.8B	17.8B	15.1B	18.9B	17.8B	22.3B	24.7B	29.2B	19.6B	16.3B	16.6B
Shares outstanding	144.9M	137.9M	134.3M	123.9M	117.8M	111.2M	108.4M	108.8M	109.3M	109.5M	109.5M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	12.6	17.4	9.96	17.8	7.68	9.86	5.83	8.61	—	—	6.78
P/S	2.12	2.4	1.69	2.42	2.71	2.19	1.15	1.55	0.74	0.49	0.53
P/B	3.78	4.48	3.58	5.26	3.93	4.12	1.82	2.24	1.35	1.04	1.24
EV/EBITDA	10.2	12.2	8.13	12.2	14.4	8.72	11.4	14.3	9.27	9.62	9.91
EV/Sales	2.55	2.9	2.12	3	3.15	2.62	2.55	2.67	1.9	1.71	1.71
Earnings yield	7.94%	5.75%	10%	5.62%	13%	10.1%	17.2%	11.6%	—	—	14.8%
FCF yield	5.67%	3.63%	10.1%	7.11%	6.4%	6.9%	11.5%	7.87%	7.02%	17.3%	18.8%
PEG	—	—	—	—	—	—	—	—	—	—	-0.18

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	26.1%	24.6%	27.6%	25.5%	22.9%	31.4%	24.6%	23.8%	22.9%	20.5%	22.5%
Operating margin	17.4%	15%	18.6%	16.4%	12.6%	22.7%	14.3%	11.1%	10.1%	8.01%	11%
Net margin	16.8%	13.8%	17%	13.6%	35.2%	22.2%	19.7%	18%	-14.7%	-12.1%	-12%
ROE	30%	25.7%	35.9%	29.6%	51.1%	41.8%	31.2%	26%	-27%	-25.7%	-22.3%
ROA	10.8%	8.9%	13%	9.05%	18.3%	15.8%	7.24%	7.38%	-6.62%	-5.31%	2.56%
ROIC	15.5%	11.7%	16.7%	13.9%	9.99%	20.2%	7.01%	6.14%	5.89%	4.73%	5.24%
Return on tangible assets	14.2%	12.3%	18.4%	12.8%	25.1%	24.7%	50.3%	41.8%	-31.5%	-16.5%	-16.6%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	2.3	1.79	1.62	1.58	1.91	1.52	1.63	1.53	1.34	1.55	1.45
Quick ratio	1.63	1.21	1.03	0.98	1.41	0.91	0.93	0.95	0.74	0.94	0.87
Debt / equity	1	1.1	1.04	1.42	1.02	0.93	2.48	1.87	2.31	2.89	2.7
Debt / assets	0.36	0.38	0.38	0.43	0.36	0.35	0.58	0.53	0.57	0.6	0.58
Net debt / EBITDA	1.74	2.07	1.64	2.34	2.01	1.43	6.26	6.01	5.69	6.89	5.98
Interest coverage	9.58	9.81	13.1	9.59	21.7	25.7	4.51	2.64	-0.47	-0.74	-0.55
Effective tax rate	11.8%	19.8%	19.3%	12.6%	11%	14.7%	0%	0%	0%	0%	0%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	37.2	44.5	53.3	50.8	48	76.8	89.2	100.6	94.1	87.2	88.6
EPS (basic)	6.21	6.11	8.99	6.88	16.9	17	17.5	18	-13.9	-10.6	-10.6
EPS (diluted)	6.18	6.09	8.91	6.84	16.8	16.9	17.3	17.9	-13.9	-10.6	-10.6
Book value per share	20.8	23.9	25.2	23.4	33.1	40.8	56.3	69.4	51.3	40.8	38
FCF per share	4.46	3.89	9.09	8.75	8.31	11.6	11.8	12.2	4.86	7.33	6.42
Cash per share	4.61	4.41	3.5	4.06	12.6	4.91	13.9	16.6	8.8	11.5	12.4
Capex per share	—	—	—	—	—	—	—	—	—	3.13	2.5

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	—	—	—	—	—	—	—	—	—	3.59%	2.84%
Capex / operating cash flow	—	—	—	—	—	—	—	—	—	29.9%	28%
Payout ratio	22.2%	28.4%	23.1%	35%	14.7%	16%	15.6%	15.5%	-20.3%	-1.13%	27.9%
Dividend yield	1.76%	1.63%	2.32%	1.97%	1.91%	1.63%	2.68%	1.8%	4.06%	0.28%	0.26%

Yield

0.26%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.03

ex-dividend Jul 28, 2026

Payout ratio

28%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Jul 28, 2026	$0.03
Apr 27, 2026	$0.03
Feb 24, 2026	$0.03

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$2.7B	$2.6B	$2.6B	$2.7B	$2.6B	$2.4B	$2.4B	$2.5B	$2.4B	$2.2B	$2.3B	$2.8B
YoY change	+18.3%	+9.41%	-8.48%	-5.15%	-2.75%	-7.75%	-8.5%	-4.49%	-8.65%	-7%	-2.18%	+8.69%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	668M	608M	470M	503M	1.5B	546M	1.5B	1.8B	962M	1.3B
Receivables	801M	986M	1B	850M	792M	1.2B	1.4B	1.2B	1.1B	922M
Inventory	720M	900M	1B	1B	978M	1.5B	2.8B	2.4B	2.3B	2.2B
Total current assets	2.5B	2.8B	2.9B	2.8B	3.8B	3.8B	6.6B	6.2B	5.1B	5.7B
Property, plant & equipment	2.9B	3B	3B	3.1B	3.3B	3.6B	4.9B	4.9B	4.6B	4.3B
Goodwill & intangibles	2B	2.6B	2.7B	2.8B	3B	4.3B	22.5B	21.9B	18.1B	14.7B
Total assets	8.4B	9.5B	9.3B	9.5B	10.9B	12B	26.3B	26.6B	22.9B	21.7B
Accounts payable	625M	807M	819M	780M	797M	1.2B	1.5B	1.5B	1.2B	1.3B
Short-term debt	118M	326M	561M	525M	532M	828M	1.4B	1.5B	1.6B	1.3B
Total current liabilities	1.1B	1.6B	1.8B	1.8B	2B	2.5B	4.1B	4.1B	3.9B	3.7B
Long-term debt	2.9B	3.3B	3B	3.6B	3.4B	3.4B	13.7B	12.6B	11.4B	11.7B
Total liabilities	5.3B	6.2B	5.9B	6.6B	7B	7.4B	20.2B	19B	17.2B	17.2B
Shareholders' equity	3B	3.3B	3.4B	2.9B	3.9B	4.5B	6.1B	7.6B	5.6B	4.5B
Total debt	3B	3.6B	3.5B	4.1B	4B	4.2B	15.1B	14.1B	13B	12.9B
Net debt	2.4B	3.1B	3.1B	3.7B	3B	3.7B	13.6B	12.3B	12B	11.7B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	—	—	—	—	—	—	—	—	1.4B	1.3B	1.8B	1.4B
Receivables	—	—	—	—	—	—	—	—	1B	922M	1.1B	1.3B
Inventory	—	—	—	—	—	—	—	—	2.2B	2.2B	2.3B	2.3B
Total current assets	—	—	—	—	—	—	—	—	6.1B	5.7B	6B	5.8B
Property, plant & equipment	—	—	—	—	—	—	—	—	5.5B	4.3B	5.3B	5.2B
Goodwill & intangibles	—	—	—	—	—	—	—	—	14.8B	14.7B	14.6B	14.5B
Total assets	—	—	—	—	—	—	—	—	22.2B	21.7B	21.7B	21.4B
Accounts payable	1.3B	1.5B	1.4B	1.5B	1.4B	1.2B	1.3B	1.3B	1.2B	1.3B	1.4B	1.5B
Short-term debt	—	—	—	—	—	—	—	—	1.3B	1.3B	1.8B	1.4B
Total current liabilities	—	—	—	—	—	—	—	—	3.7B	3.7B	4.3B	4B
Long-term debt	—	—	—	—	—	—	—	—	11.9B	11.7B	11.1B	11B
Total liabilities	—	19B	18.5B	18.2B	18.2B	17.3B	17.6B	18B	17.8B	17.2B	17.3B	16.8B
Shareholders' equity	—	—	—	—	—	—	—	—	4.4B	4.5B	4.5B	4.6B
Total debt	—	—	—	—	—	—	—	—	13.2B	12.9B	12.9B	12.4B
Net debt	—	—	—	—	—	—	—	—	11.8B	11.7B	11.1B	11B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	906M	849M	1.2B	858M	2B	1.9B	1.9B	2B	-1.5B	-1.2B
Depreciation & amortization	295M	310M	349M	356M	356M	378M	478M	739M	823M	786M
Stock-based compensation	31M	47M	71M	48M	28M	95M	60M	40M	32M	24M
Change in working capital	-118M	173M	-248M	151M	280M	-488M	280M	516M	-204M	235M
Operating cash flow	808M	796M	1.4B	1.3B	2.6B	1.7B	1.8B	2.3B	-676M	1.1B
Capital expenditure	—	—	—	—	—	—	—	—	—	-343M
Investing cash flow	-193M	-282M	-170M	-123M	956M	-652M	-10.6B	434M	-35M	-349M
Dividends paid	-201M	-241M	-280M	-300M	-293M	-304M	-297M	-305M	-307M	-13M
Share repurchases	-500M	-500M	-805M	-996M	-650M	-1B	-17M	0	0	—
Financing cash flow	-1.2B	-476M	-1.3B	-1B	-2.2B	-1B	10.3B	-2.3B	-1.7B	-1.1B
Net change in cash	-592M	38M	-42M	147M	1.3B	35M	1.5B	362M	-2.4B	-353M
Free cash flow	647M	536M	1.2B	1.1B	979M	1.3B	1.3B	1.3B	531M	803M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	949M	701M	124M	153M	120M	-1.9B	-17M	205M	-1.4B	22M	48M	129M
Depreciation & amortization	185M	195M	227M	198M	209M	189M	191M	193M	201M	201M	208M	249M
Stock-based compensation	4M	4M	10M	10M	3M	9M	5M	7M	7M	5M	8M	10M
Change in working capital	-1M	509M	-210M	-99M	-274M	379M	-197M	79M	186M	159M	-109M	-122M
Operating cash flow	844M	732M	136M	263M	58M	-1.1B	26M	410M	447M	252M	76M	209M
Capital expenditure	—	—	—	—	—	—	—	-93M	-64M	-84M	-66M	-62M
Investing cash flow	506M	-40M	-14M	-3M	5M	-40M	4M	-88M	-59M	-104M	425M	-59M
Dividends paid	-76M	-77M	-77M	-77M	-76M	-77M	-3M	-3M	-3M	-4M	-3M	-3M
Share repurchases	0	0	—	—	—	—	—	—	—	—	—	—
Financing cash flow	-911M	-240M	-678M	-489M	-376M	-189M	-300M	-326M	-118M	-406M	-46M	-546M
Net change in cash	439M	452M	-556M	-229M	-313M	-1.4B	-270M	-4M	270M	-258M	455M	-396M
Free cash flow	272M	702M	-36M	187M	-9M	389M	-65M	317M	383M	168M	10M	147M

Celanese Corp Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement